XML 27 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segments and Disaggregated Revenue
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segments and Disaggregated Revenue
13.

Segments and Disaggregated Revenue 



 

 

Construction

 


                Medical

              Development



Corporate and support

 


Consolidated

 


Nine Months Ended September 30, 2022





















Revenue 

$ 8,648,873

$ 11,640,953

$

$

$ 20,289,826

Cost of revenue



8,689,924


8,506,681








17,196,605

Operating expenses



399,911


52,336


879,158


5,172,966


6,504,371

Operating income (loss)

(440,962 )

3,081,936


(879,158 )

(5,172,966 )

(3,411,150 )

Other income (expense)

487,339




(173,726 )

33,518

347,131

Income (loss) before income taxes

46,377

3,081,936


(1,052,884 )

(5,139,448 )

(3,064,019 )

Net income attributable to non-controlling interest




1,522,101








1,522,101

Net income (loss) attributable to common stockholders of SG Blocks, Inc.
$ 46,377
$ 1,559,835

$ (1,052,884 )
$ (5,139,448 )
$ (4,586,120 )























Total assets
$ 11,442,445

$ 2,191,019

$ 8,947,444

$ 6,376,008

$ 28,956,916

Depreciation and amortization
$
429,056

$ 40,230

$

$

$ 469,286

Capital expenditures
$ 1,094,222

$

$ 893,785

$ 8,193

$ 1,996,200


























Construction




Medical




Development




Corporate and support




Consolidated



Nine Months Ended September 30, 2021 

 



 







  





 






Revenue
$ 5,983,027

$ 23,906,077

$

$

$ 29,889,104

Cost of revenue



10,469,990


17,328,003








27,797,993

Operating expenses



295,392


515,184


62,851


5,029,816


5,903,243

Operating income (loss)

(4,782,355 )

6,062,890


(62,851 )

(5,029,816 )

(3,812,132 )

Other income (expense)

(35,167 )





102,717

67,550

Income (loss) before income taxes

 


(4,817,522

)

6,062,890


(62,851

)

 

(4,927,099

)

 

(3,744,582 )

Net income attributable to non-controlling interest

 


 



3,661,459








3,661,459

Net income (loss) attributable to common stockholders of SG Blocks, Inc.
$ (4,817,522 )
$ 2,401,431

$ (62,851 )
$ (4,927,099 )
$ (7,406,041 )























Depreciation and amortization
$ 406,371

$ 42,335

$

$ 795

$ 449,501



 

 

Construction

 


                Medical

              Development   



Corporate and support

 


Consolidated

 


Three Month Ended September 30, 2022




















Revenue 

$ 2,692,519

$ 1,437,738

$

$

$ 4,130,257

Cost of revenue



2,693,451


1,601,980








4,295,431

Operating expenses



192,266


25,271


281,302


1,838,173


2,337,012

Operating income (loss)

(193,198 )

(189,513 )

(281,302 )

(1,838,173 )

(2,502,186 )

Other income (expense)

(3,563 )




(52,157 )

9,755

(45,965 )

Income (loss) before income taxes

(196,761 )

(189,513 )

(333,459 )

(1,828,418 )

(2,548,151 )

Net income attributable to non-controlling interest




(94,568)







(94,568)

Net income (loss) attributable to common stockholders of SG Blocks, Inc.
$ (196,761 )
$ (94,945 )
$ (333,459 )
$ (1,828,418 )
$ (2,453,583 )























Depreciation and amortization
$ 142,301
$ 13,410
$ 2,157
$

$ 157,868

Capital expenditures
$
244,201
$

$

$

$ 244,201


























Construction




Medical




Development




Corporate and support




Consolidated



Three Months Ended September 30, 2021 

 



 







  





 






Revenue
$ 682,866

$ 8,164,624

$

$

$ 8,847,490

Cost of revenue



3,139,213


6,315,098








9,454,311

Operating expenses



81,258


145,117


8,949


1,884,463


2,119,787

Operating income (loss)

(2,537,605 )

1,704,409


(8,949 )

(1,884,463 )

(2,726,608 )

Other income (expense)

(35,499 )

(13 )



11,463

(24,049 )

Income (loss) before income taxes

 


(2,573,104

)

1,704,396


(8,949

)

 

(1,873,000

)

 

(2,750,657 )

Net income attributable to non-controlling interest

 


 



1,080,248







1,080,248

Net income (loss) attributable to common stockholders of SG Blocks, Inc.
$ (2,573,104 )
$ 624,148

$ (8,949 )
$ (1,873,000 )
$ (3,830,905 )























Depreciation and amortization


$ 129,785

$ 15,730

$

$

$ 145,515